Higher concentrations of heparin and hirudin are required to inhibit thrombin generation in tissue factor-activated cord plasma than in adult plasma

Pediatric Research

Volumn 57, Issue 5 I, 2005, Pages 685-689

  Baier, Katrin ^a   Cvirn, Gerhard ^a   Fritsch, Peter ^a   Köstenberger, Martin ^a   Gallistl, Siegfried ^a   Leschnik, Bettina ^a   Muntean, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; HIRUDIN; THROMBIN; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; CONCENTRATION RESPONSE; DOSE CALCULATION; HUMAN; HUMAN TISSUE; NEWBORN; NEWBORN PERIOD; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; THROMBIN TIME; UMBILICAL CORD BLOOD;

ADULT; AGE FACTORS; ANTICOAGULANTS; ANTITHROMBINS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FETAL BLOOD; FIBRINOLYTIC AGENTS; HEPARIN; HIRUDINS; HUMANS; INFANT, NEWBORN; THROMBIN; THROMBOPLASTIN;

EID: 17744378749     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000156515.49293.F8     Document Type: Article

References (24)

1. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Powers P 1987 Development of the human coagulation system in the full-term infant. Blood 70:165-172
2. Mitchell L, Piovella F, Ofosu F, Andrew M 1991 Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children. Blood 78:2299-2304
3. Chan AK, Berry LR, Monagle PT, Andrew M 2002 Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential. Thromb Haemost 87:606-613
4. Hemker HC, Wielders S, Kessels H, Beguin S 1993 Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 70:617-624
5. Hemker HC, Willems GM, Beguin S 1986 A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 56:9-17
6. Wielders S, Mukherjee M, Michiels J, Rijkers DT, Cambus JP, Knebel RW, Kakkar V, Hemker HC, Beguin S 1997 The routine determination of the endogenous thrombin potential, first results in different forms of hyper- and hypocoagulability. Thromb Haemost 77:629-636
7. Andrew M, Schmidt B, Mitchell L, Paes B, Ofosu F 1990 Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin. Thromb Haemost 63:27-30
8. Davie EW, Fujikawa K, Kisiel W 1991 The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30:10363-10370
9. Butenas S, van't Veer C, Mann KG 1999 "Normal" thrombin generation. Blood 94:2169-2178
10. Cvirn G, Gallistl S, Rehak T, Jürgens G, Muntean W 2003 Elevated thrombin-forming capacity of tissue factor-activated cord compared with adult plasma. J Thromb Haemost 1:1785-1790
11. Cvirn G, Gallistl S, Leschnik B, Muntean W 2003 Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates. J Thromb Haemost 1:263-268
12. Cvirn G, Gallistl S, Koestenberger M, Kutschera J, Leschnik B, Muntean W 2002 Alpha 2-macroglobulin enhances prothrombin activation and thrombin potential by inhibiting the anticoagulant protein C/protein S system in cord and adult plasma. Thromb Res 105:433-439
13. Cvirn G, Gallistl S, Muntean W 2001 Alpha-2-macroglobulin inhibits the anticoagulant action of activated protein C in cord and adult plasma. Haemostasis 31:1-11
14. Cvirn G, Gallistl S, Muntean W 2001 Effects of alpha (2)-macroglobulin and antithrombin on thrombin generation and inhibition in cord and adult plasma. Thromb Res 101:183-191
15. Cvirn G, Gallistl S, Muntean W 1999 Effects of antithrombin and protein C on thrombin generation in newborn and adult plasma. Thromb Res 93:183-190
16. van't Veer C, Golden NJ, Kalafatis M, Mann KG 1997 Inhibitory mechanism of the protein C pathway on tissue factor-activated thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor. J Biol Chem 272:7983-7994
17. van't Veer C, Mann KG 1997 Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II. J Biol Chem 272:4367-4377
18. David M, Andrew M 1994 Venous thromboembolic complications in children. J Pediatr 124:831-832
19. Andrew M, David M, Adams M, Ali M, Anderson R, Barnard D, Bernstein M, Brisson L, Cairney B, DeSai D, Grant R, Israels S, Jardine L, Luke B, Massicote P, Silvia M 1994 Venous thromboembolic complications (VTE) in children: first analyses of the Canadian registry of VTE. Blood 83:1251-1257
20. David M, Andrew M Venous thromboembolic complications in children J Pediatr 123:337-346, 1993
21. Mann KG, Brummel K, Butenas S 2003 What is all that thrombin for? J Thromb Haemost 1:1504-1514
22. Schmidt B, Mitchell L, Ofosu F, Andrew M 1989 Alpha-2-macroglobulin is an important progressive inhibitor of thrombin in neonatal and infant plasma. Thromb Haemost 62:1074-1077
23. Viera A, Berry L, Ofosu F, Andrew M 1991 Heparin sensitivity and resistance in the neonate: an explanation. Thromb Res 63:85-98
24. Linder R, Blomback M, Egberg N, Grip L 1999 Thrombin inhibitors suppress the thrombin-thrombomodulin-mediated generation of activated protein C. Thromb Res 95:117-125